Nisa Investment Advisors
PRDS

Nisa Investment Advisors’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Nisa Investment Advisors’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-188
Closed -$340 – 2876
2023
Q2 		$340 Hold
188
– – ﹤0.01% 2638
2023
Q1 		$0 Buy
188
+50
+36% +$82 ﹤0.01% 2782
2022
Q4 		$0 Buy
+138
New +$175 ﹤0.01% 2781

Other funds holding PRDS

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nisa Investment Advisors's PRDS Position: Q3 2023 in Review

Nisa Investment Advisors sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 188 shares — an estimated $340 sold.

Nisa Investment Advisors first reported a position in PRDS in Q4 2022 and held it in 3 quarters. The position peaked at $340 in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

  • Nisa Investment Advisors reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 188 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $340.
  • Nisa Investment Advisors first reported a position in Pardes Biosciences, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Nisa Investment Advisors's Pardes Biosciences, Inc. Common Stock position peaked at $340 in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Nisa Investment Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.